Granite Bio

Developer of therapeutic antibodies that target inflammatory, autoimmune, and fibrotic conditions

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2021 language granitebio.com

Registered entities

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 61 times.

YearFilings
20231
20242
20251
20261

Investor mix

4 investors on record; lead investors include Versant Ventures, Novartis Venture Fund, Forbion, Sanofi Ventures.

Investor typeCountShare
Venture capital4100%
Coming soon